1. Home
  2. APGE vs DLO Comparison

APGE vs DLO Comparison

Compare APGE & DLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$134.08

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo DLocal Limited

DLO

DLocal Limited

HOLD

Current Price

$14.26

Market Cap

4.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
DLO
Founded
2022
2013
Country
United States
Uruguay
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.4B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
APGE
DLO
Price
$134.08
$14.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
8
Target Price
$109.67
$17.25
AVG Volume (30 Days)
5.4M
3.2M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
1.45%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$41.00
Revenue Next Year
N/A
$26.98
P/E Ratio
N/A
$22.27
Revenue Growth
N/A
N/A
52 Week Low
$34.34
$9.81
52 Week High
$134.35
$16.78

Technical Indicators

Market Signals
Indicator
APGE
DLO
Relative Strength Index (RSI) 80.75 53.65
Support Level $80.52 $13.21
Resistance Level N/A $14.80
Average True Range (ATR) 0.43 0.61
MACD -1.69 -0.08
Stochastic Oscillator 86.53 23.51

Price Performance

Historical Comparison
APGE
DLO

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.

Share on Social Networks: